Research Article

Intracranial Angioplasty with Enterprise Stent for Intracranial Atherosclerotic Stenosis: A Single-Center Experience and a Systematic Review

Table 1

The patient’s demographic data, clinical and angiographic outcome.

CharacteristicValue

Age, years ()
Sex, male/female ()60/44
Qualifying event ( (%))
 Transient ischemic attack21 (20.19)
 Cerebral infarction83 (79.81)
Comorbidities ( (%))
 Hypertension80 (76.92)
 Diabetes30 (28.85)
 Coronary artery disease18 (17.31)
Pretreated modified Rankin scale score ( (%))
 017 (16.35)
 169 (66.35)
 216 (15.38)
 31 (0.96)
Location ( (%))
 Intracranial segment of internal carotid artery13 (12.38)
 Middle cerebral artery34 (32.38)
 Basilar artery43 (40.95)
 Intracranial segment of the vertebral artery15 (14.28)
Lesion morphology ( (%))
 A14 (13.33)
 B40 (38.10)
 C51 (48.57)
Complications ( (%))
 Any stroke or death within 30 d7 (6.73)
 Nonfatal ischemic stroke within 30 d4 (3.85)
 Nonfatal hemorrhage stroke within 30 d2 (1.92)
 Death within 30 d1 (0.96)
Angiographic outcome
 Pretreated stenosis degree (%) ()
 Posttreated stenosis degree (%) ()
 Length of stenosis ()
 Enterprise stent length (mm) ()
 Balloon catheter length (mm) ()